Expect the unexpected. CRISPR week roundup

omg

CRISPR binge-watchers have eyes wide shut. Medicine historian Nathaniel Comfort demolishes for Nature the long-awaited book by the queen of genome editing Jennifer Doudna “A crack in creation”. CRISPR stocks fall after the publication of a small preliminary study on off-target mutations. New Scientist announces as many as 20 human trials will be under way soon, mostly in China.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s